CD8+ As a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. VER 2025, 8 (13s), 155-161. https://doi.org/10.64149/.